Indelicato Elisabetta, Zech Michael, Eberl Anna, Boesch Sylvia
Center for Rare Movement Disorders Innsbruck, Department of Neurology, Medical University Innsbruck, Anichstrasse 35, Innsbruck, 6020, Austria.
Institute of Neurogenomics, Helmholtz Munich, Neuherberg, Germany.
Curr Neurol Neurosci Rep. 2025 Mar 17;25(1):24. doi: 10.1007/s11910-025-01414-w.
Large-scale studies using hypothesis-free exome sequencing have revealed the strong heritability of neurodevelopmental disorders (NDDs) and their molecular overlap with later-onset, progressive, movement disorders phenotypes. In this review, we focus on the shared genetic landscape of NDDs and movement disorders.
Cumulative research has shown that up to 30% of cases labelled as "cerebral palsy" have a monogenic etiology. Causal pathogenic variants are particularly enriched in genes previously associated with adult-onset progressive movement disorders, such as spastic paraplegias, dystonias, and cerebellar ataxias. Biological pathways that have emerged as common culprits are transcriptional regulation, neuritogenesis, and synaptic function. Defects in the same genes can cause neurological dysfunction both during early development and later in life. We highlight the implications of the increasing number of NDD gene etiologies for genetic testing in movement disorders. Finally, we discuss gaps and opportunities in the translation of this knowledge to the bedside.
使用无假设外显子组测序的大规模研究揭示了神经发育障碍(NDDs)的强遗传性及其与迟发性、进行性运动障碍表型的分子重叠。在本综述中,我们聚焦于NDDs和运动障碍的共同遗传格局。
累积研究表明,高达30%被标记为“脑瘫”的病例具有单基因病因。因果致病变体在先前与成人起病的进行性运动障碍相关的基因中尤其富集,如痉挛性截瘫、肌张力障碍和小脑共济失调。已成为常见罪魁祸首的生物学途径是转录调控、神经突发生和突触功能。同一基因的缺陷可在早期发育期间和生命后期导致神经功能障碍。我们强调了越来越多的NDD基因病因对运动障碍基因检测的影响。最后,我们讨论了将这些知识转化为临床应用方面的差距和机遇。